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   A previously healthy 26 year old African American male presented to the ED with the acute onset of right-sided 
posterior thoracic pain and shortness of breath over the previous four hours.  He described the pain as severe, 
sharp and exacerbated by deep inspiration and reported that it radiated to the RUQ and anterior chest wall.  He 
denied fever, chills, cough, trauma to the chest wall or a history of similar episodes in the past.  He denied the use 
of IV drugs and had no known exposure to TB; however, he did admit to a history of tobacco use (1/2 ppd for two 
years), a history of inhaling cocaine (most recently two days ago) and a history of incarceration several years 
prior to this presentation. 
Physical exam on admission demonstrated that he was alert and fully oriented.  Vitals were WNL except for 
tachypnea with shallow respirations; his O2 Sat was 97%.  He was lying very still for his exam and grimaced with 
any movement.  The ENT exam was unremarkable and his trachea was midline though asymmetric chest motion 
was noted, with diminished chest expansion on the right.  In the supine position, his right chest was tender to 
palpation, hyperresonant to percussion anteriorly and dull to percussion laterally.  He was mildly tender to pal-
pation in the RUQ.  The remainder of his exam was normal. 
Admission labs revealed a WBC of 6.5, Hgb 10.5, Hct 31.7, MCV 92.3 and Platelet count of 143.  Coagulation stud-
ies were normal.  BMP was normal except for BUN 26 and Cr 1.4; LFTs, serum amylase and serum lipase were all 
normal.  Cardiac enzymes were normal and a UA was unremarkable.  ABGs on supplemental oxygen via nasal 
cannula revealed pH 7.3, pCO2 45, pO2 111, HCO3 24, BE –0.6 and O2 sat of 98.7%.  A rapid HIV was negative 
and a PPD later proved to be negative.  A CXR and CT Chest revealed a right hydropneumothorax, possibly rep-
resenting a large empyema (see images below).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Empiric IV antibiotics were ordered and a chest tube was placed with the immediate return of 1 liter of bloody 
fluid, free of clots.  Pleural fluid studies were not consistent with empyema but, rather, suggested a hemothorax: 
the fluid HCT was 30.1%, the gram stain was negative and cultures, including mycobacteria, were all negative.  
Cytology of the pleural fluid revealed RBCs but was negative for malignant cells.  Following placement of the 
chest tube and initiation of IV hydration, his Hgb remained stable, renal function normalized and the lung (cont) 
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Rise  (cont) re-expanded without evidence of underlying mass or infiltrate.  The patient remained afebrile and had no 
leukocytosis throughout his hospital stay; the chest tube was removed without complication and he was dis-
charged to home. 
DISCUSSION: 
The recreational use of cocaine can be traced back to early civilizations.  Originally documented by the ancient 
Moche tribe of Peru over 2500 years ago, the practice of liberating cocaine from coca leaves (using lime produced 
from roasted sea shells) was still occurring in Venezuela in 1499, at the time of Amerigo Vespucci.  Cocaine’s abil-
ity to alter physiologic activity was clear to even the early users of the drug.  Cieza de Leon wrote “When I in-
quired of certain Indians why they keep their mouths ever filled with that herb…..they say that they have little 
sense of hunger and feel great vigor and strength.” [1]  The ability of cocaine to induce such feelings of euphoria 
is likely responsible for its popularity in modern-day culture. 
Cocaine can be introduced to the body in a multitude of ways.  Popular methods include inhalation, intravenous 
injection or mucosal absorption (intranasal, sublingual, intravaginal or rectal).  Inhalation results in a more rapid 
onset of action and a shorter time to peak effects than other methods [2].  The mechanism by which the drug is 
introduced is an important consideration when evaluating a patient for pathologic effects. 
Pulmonary complications are common in patients who inhale cocaine.  Cough is present in 26-61% of subjects 
and hemoptysis develops in up to 26% [4].  Bleeding may result from rupture of submucosal vessels or directly 
from the alveolar-capillary membrane.  Autopsy series  have revealed that 85% of patients who died from cocaine 
intoxication had evidence of pulmonary hemorrhage [5].  Pneumothorax, pneumomediastinum and pneumoperi-
cardium may occur less frequently but are also well-documented complications of cocaine inhalation.  In one 
study of 71 crack smokers who presented to an ER with chest pain, two were found to have pneumomediasti-
num, one had a pneumothorax and one had a hemopneumothorax, directly attributed to the cocaine inhalation 
[4]. 
The manner in which the cocaine is inhaled and the techniques used to increase absorption across the pulmonary
-capillary barrier can predispose the patient to barotrauma.  Users attempt to introduce cocaine into the pulmo-
nary system by maximal inhalation; once the peak inspiratory volume is achieved, users resort to one of several 
methods to enhance absorption of the drug into the bloodstream.  These techniques include the Valsalva maneu-
ver and the forceful exhalation by a smoking partner into the mouth of the user [3].  Additionally, severe cough-
ing may be induced by irritation from the cocaine powder.  All three of these factors trigger a sudden increase in 
intra-alveolar pressure that may exceed the elastic potential of the parenchyma, resulting in alveolar rupture [3]. 
Treatment of pneumothorax or hemothorax due to cocaine inhalation is similar to that for spontaneous pneu-
mothorax: chest tube placement, supplemental oxygen and supportive care, including pain management.  Of 
course, cessation of cocaine use is an important part of the therapy and a referral to a drug abuse treatment pro-
gram should be considered. [3]  
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